Published in Liver Transpl on September 01, 2000
Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care (2012) 1.30
Comparison of three methods of nutritional assessment in liver cirrhosis: subjective global assessment, traditional nutritional parameters, and body composition analysis. J Gastroenterol (2006) 0.99
Anthropometric, biochemical and clinical assessment of malnutrition in Malaysian patients with advanced cirrhosis. Nutr J (2010) 0.96
Malnutrition: laboratory markers vs nutritional assessment. Gastroenterol Rep (Oxf) (2016) 0.88
Serum cystatin C level is a useful marker for the evaluation of renal function in patients with cirrhotic ascites and normal serum creatinine levels. Korean J Hepatol (2011) 0.87
Nutritional status of patients with alcoholic cirrhosis undergoing liver transplantation: time trends and impact on survival. Transpl Int (2013) 0.82
The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists. Dig Dis Sci (2011) 0.82
Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol (2016) 0.81
Nutrition in the management of cirrhosis and its neurological complications. J Clin Exp Hepatol (2013) 0.81
Nutritional assessment in cirrhotic patients with hepatic encephalopathy. World J Hepatol (2015) 0.79
Nutritional status and liver transplantation. J Clin Exp Hepatol (2012) 0.79
Masseter muscle tension, chewing ability, and selected parameters of physical fitness in elderly care home residents in Lodz, Poland. Clin Interv Aging (2014) 0.79
Nutrition assessment in patients undergoing liver transplant. Indian J Crit Care Med (2014) 0.77
Reprint of: Nutrition in the Management of Cirrhosis and its Neurological Complications. J Clin Exp Hepatol (2015) 0.76
Sarcopenia and liver transplant: The relevance of too little muscle mass. World J Gastroenterol (2015) 0.76
Serum Leptin Is a Biomarker of Malnutrition in Decompensated Cirrhosis. PLoS One (2016) 0.76
PROUD: effects of preoperative long-term immunonutrition in patients listed for liver transplantation. Trials (2007) 0.76
Nutrition assessment and its effect on various clinical variables among patients undergoing liver transplant. Hepatobiliary Surg Nutr (2016) 0.75
Total kidney and liver volume is a major risk factor for malnutrition in ambulatory patients with autosomal dominant polycystic kidney disease. BMC Nephrol (2017) 0.75
Sialadenosis in patients with advanced liver disease. Head Neck Pathol (2009) 0.75
Prevalence and predictors of low muscle mass in HIV/viral hepatitis coinfection. AIDS (2016) 0.75
A model to predict survival in patients with end-stage liver disease. Hepatology (2001) 18.06
MELD and PELD: application of survival models to liver allocation. Liver Transpl (2001) 3.76
Endoscopic perforation of the colon: lessons from a 10-year study. Am J Gastroenterol (2000) 3.52
Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. JAMA (2000) 3.15
Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology (1997) 2.83
A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med (1997) 2.66
Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol (1978) 2.63
Splenosis: autotransplantation of splenic tissue. Am J Med (1976) 2.53
Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology (1989) 2.39
Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial. Ann Intern Med (1991) 2.37
Diagnostic plots to reveal functional form for covariates in multiplicative intensity models. Biometrics (1995) 2.19
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology (1994) 2.10
Cost-effectiveness of ultrasound-guided liver biopsy. Hepatology (1998) 2.06
Secular trends in hip fracture incidence and recurrence. Osteoporos Int (2008) 2.04
Optimists vs pessimists: survival rate among medical patients over a 30-year period. Mayo Clin Proc (2000) 2.02
Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiography. Chest (1990) 1.99
Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med (1989) 1.94
Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am J Transplant (2010) 1.93
Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. Gastroenterology (1996) 1.87
Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection. Am J Transplant (2008) 1.86
A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis. N Engl J Med (1990) 1.81
Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system. Leukemia (2008) 1.77
Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study. Gastroenterology (1990) 1.76
Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol (1990) 1.74
Long-term trends in hip fracture prevalence: the influence of hip fracture incidence and survival. Osteoporos Int (1998) 1.69
Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology (1997) 1.63
Hepatopulmonary syndrome. Clinical observations and lack of therapeutic response to somatostatin analogue. Chest (1993) 1.61
Copper and primary biliary cirrhosis. Gastroenterology (1974) 1.59
Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Mayo Clin Proc (1993) 1.59
Designs for group sequential phase II clinical trials. Biometrics (1987) 1.57
Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology (2000) 1.55
Phase II evaluation of menogaril in patients with advanced hypernephroma. Invest New Drugs (1991) 1.53
Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation. Hepatology (1993) 1.53
Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women. Epidemiology (2001) 1.53
Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology (1992) 1.51
Evaluation of consultation-based rehabilitation for hospitalized cancer patients with functional impairment. Mayo Clin Proc (1999) 1.48
Systemic giant-cell arteritis with polymyalgia rheumatica, reversible abnormalities of liver function. JAMA (1973) 1.48
Effect of ursodeoxycholic acid on serum lipids of patients with primary biliary cirrhosis. Mayo Clin Proc (1994) 1.47
Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology (1998) 1.46
A revised natural history model for primary sclerosing cholangitis. Mayo Clin Proc (2000) 1.45
Iron overload in cirrhosis-HFE genotypes and outcome after liver transplantation. Hepatology (2000) 1.45
Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival. J Clin Oncol (2001) 1.45
Recurrence of nonalcoholic steatohepatitis following liver transplantation. Transplantation (1996) 1.44
Anaesthetic management of a patient with Charcot-Marie-Tooth disease for staged diaphragmatic plication. Br J Anaesth (2013) 1.44
Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS. Leukemia (2012) 1.44
Lymphocyte cytotoxicity and inhibition studied with autologous liver cells: observations in chronic active liver disease and the primary biliary cirrhosis syndrome. Gastroenterology (1976) 1.43
The autologous mixed lymphocyte reaction in primary biliary cirrhosis: analysis of activation and blastogenesis of autoreactive T lymphocytes. Hepatology (1988) 1.43
Orthotopic liver transplantation for preoperative early-stage hepatocellular carcinoma. Mayo Clin Proc (1994) 1.43
Normalization of two-channel microarray experiments: a semiparametric approach. Bioinformatics (2004) 1.42
Nutritional support for liver transplantation: identifying caloric and protein requirements. Mayo Clin Proc (1994) 1.42
Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. Hepatology (1996) 1.41
Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis. Liver Transpl Surg (1999) 1.41
Keeping hostility in perspective: coronary heart disease and the Hostility Scale on the Minnesota Multiphasic Personality Inventory. Mayo Clin Proc (1993) 1.41
Daclizumab induction therapy in liver transplant recipients with renal insufficiency. Aliment Pharmacol Ther (2010) 1.40
Clinical significance of nuclear DNA ploidy pattern in nonseminomatous germ cell testicular tumors. Urology (1994) 1.39
Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Liver Transpl (2001) 1.38
Bolus versus infusion regimens of etoposide and cisplatin in treatment of non-small cell lung cancer: a study of the North Central Cancer Treatment group. J Natl Cancer Inst (1990) 1.37
Gastrointestinal basidiobolomycosis in Arizona: clinical and epidemiological characteristics and review of the literature. Clin Infect Dis (2001) 1.36
Autoimmune associations in primary biliary cirrhosis. Mayo Clin Proc (1982) 1.36
Changing concepts in the surgical treatment of gallstone ileus: a review of 15 cases with emphasis on diagnosis and treatment. Ann Surg (1968) 1.34
Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology (1985) 1.34
Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol (1991) 1.33
Diagnosis of Wilson's disease presenting as fulminant hepatic failure. Gastroenterology (1983) 1.33
Lumbar lordosis and pelvic inclination in adults with chronic low back pain. Phys Ther (2000) 1.30
Acute lung injury prediction score: derivation and validation in a population-based sample. Eur Respir J (2010) 1.30
Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology (1996) 1.29
Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest (1995) 1.29
Regression analysis for comparing protein samples with 16O/18O stable-isotope labeled mass spectrometry. Bioinformatics (2006) 1.27
Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology (1999) 1.26
Bone disease in primary biliary cirrhosis: independent indicators and rate of progression. J Hepatol (2001) 1.24
Crohn's disease of the esophagus: clinical features and outcomes. Inflamm Bowel Dis (2001) 1.24
Long-term survival (10 years or more) in 30 patients with primary amyloidosis. Blood (1999) 1.24
Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med (1985) 1.23
Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation (1996) 1.22
The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database. Am J Transplant (2008) 1.22
Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet (1993) 1.21
Primary biliary cirrhosis: prediction of short-term survival based on repeated patient visits. Hepatology (1994) 1.21
Retrospective cohort study of 148 patients with polyclonal gammopathy. Mayo Clin Proc (2001) 1.20
Cost-effectiveness of 6 and 12 months of interferon-alpha therapy for chronic hepatitis C. Ann Intern Med (1997) 1.20
Increased risk of chronic liver failure in adults with heterozygous alpha1-antitrypsin deficiency. Hepatology (1998) 1.19